Greater angiogenic and immunoregulatory potency of bFGF and 5-aza-2ʹ-deoxycytidine pre-treated menstrual blood stem cells in compare to bone marrow stem cells in rat model of myocardial infarction

BACKGROUND: This study is designed to compare the menstrual blood stem cells (MenSCs) and bone marrow stem cells (BMSCs)-secreted factors with or without pre-treatment regimen using basic fibroblast growth factor (bFGF) and 5-aza-2ʹ-deoxycytidine (5-aza) and also regenerative capacity of pre-treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Manshori, Mahmood, Kazemnejad, Somaieh, Naderi, Nasim, Darzi, Maryam, Aboutaleb, Nahid, Golshahi, Hannaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805241/
https://www.ncbi.nlm.nih.gov/pubmed/36587199
http://dx.doi.org/10.1186/s12872-022-03032-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805241/
https://www.ncbi.nlm.nih.gov/pubmed/36587199
http://dx.doi.org/10.1186/s12872-022-03032-7

Ejemplares similares